Observational, Non-Interventional Study Supporting Validation of VO2Max Estimation Methods Using Results in Patients Receiving Standard of Care Cardiopulmonary Exercise Tests (CPET)
NCT ID: NCT05678530
Last Updated: 2025-12-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1000 participants
OBSERVATIONAL
2019-06-06
2027-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy
Healthy Subjects who undergo the CPET
No interventions assigned to this group
Standard of Care
Standard of Care subjects who undergo the CPET as part of routine Standard of Care
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Willing to sign and date informed consent document for study participation.
3. Participant is undergoing the Cardiopulmonary Exercise Test (CPET) as Standard of Care
Exclusion Criteria
2. Participant has limited or no intrinsic sinus node function (i.e. chronic atrial pacing).
• If participant has an indwelling cardiac device and programming cannot be sufficiently ascertained to assure sinus node competence and lack of atrial pacing, the patient should be excluded.
3. Barostim (™) or similar noncardiac electrical pulse generating device in situ.
4. Complex congenital heart disease (even repaired or palliated) with the following exception:
• Biventricular physiology without severe valvar dysfunction (e.g. free pulmonary insufficiency) at the discretion of the investigator.
5. Any history of allergy to adhesive
6. Any cognitive or physical limitations that, in the opinion of the investigator, limits the participant's ability to fully follow study procedures and/or reach a respiratory exchange ratio of 1.0.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Prolaio
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Greg Kurio, MD
Role: STUDY_DIRECTOR
Prolaio, Inc
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic Arizona
Scottsdale, Arizona, United States
VA Palo Alto Healthcare System
Palo Alto, California, United States
University of California San Francisco
San Francisco, California, United States
The Lundquist Institute
Torrance, California, United States
Nemours Cardiac Center
Wilmington, Delaware, United States
Memorial Healthcare System, Office of Human Research
Hollywood, Florida, United States
Mayo Clinic Florida
Jacksonville, Florida, United States
New Generation of Medical Research
Naples, Florida, United States
physIQ
Chicago, Illinois, United States
University of Illinois Hospital & Health Sciences System
Chicago, Illinois, United States
Advocate Aurora Health Institute
Oakbrook Terrace, Illinois, United States
Mayo Clinic
Rochester, Minnesota, United States
Baylor Scott & White Research Institute
Dallas, Texas, United States
Baylor Scott & White The Heart Hospital - Plano
Plano, Texas, United States
Intermountain Medical Center
Murray, Utah, United States
Eastern Health Cardiac Rehabilitation
St. John's, Newfoundland and Labrador, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Research Technologist
Role: primary
Clinical Research Coordinator
Role: primary
Clinical Research Coordinator
Role: primary
Clinical Trial Project Manager
Role: primary
Research Coordinator
Role: backup
Research Program Manager
Role: primary
Clinical Research Coordinator
Role: primary
Clinical Research Coordinator
Role: primary
Clinical Research Coordinator
Role: primary
Dr. Cemal Ozemek
Role: primary
Research Technologist
Role: primary
Research Enrollment Analyst
Role: primary
Supervisor Clinical Research
Role: primary
Project Coordinator, Outpatient Pulmonary Research
Role: primary
Clinical Research Coordinator
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CTP-020
Identifier Type: -
Identifier Source: org_study_id